Home » Stocks » CFX

Colfax Corporation (CFX)

Stock Price: $38.73 USD -1.02 (-2.57%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 4.59B
Revenue (ttm) 3.13B
Net Income (ttm) -7.45M
Shares Out 118.39M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE 20.28
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $38.73
Previous Close $39.75
Change ($) -1.02
Change (%) -2.57%
Day's Open 39.18
Day's Range 37.91 - 39.39
Day's Volume 985,250
52-Week Range 14.64 - 40.59

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Forbes - 2 days ago

After reaching record highs last week, the major indices sold off Monday and have since failed to stage a significant rally. For now, stocks look overstretched, and inflation could be right ar...

Other stocks mentioned: BLMN, FUN, USFD
Zacks Investment Research - 2 days ago

The industrial sector is gearing up for growth in 2021. ParkerHannifin (PH), Fortune Brands (FBHS), Reliance Steel (RS), Rexnord (RXN) and Colfax (CFX) are performing well and are set to grow.

Other stocks mentioned: FBHS, PH, RS, RXN
Zacks Investment Research - 1 week ago

Let's see if Colfax (CFX) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks Investment Research - 1 month ago

Colfax's (CFX) acquisition of LiteCure will create strong growth opportunities for DJO in the physical therapy and rehabilitation market.

Zacks Investment Research - 1 month ago

Colfax's (CFX) product launches, exposure in multiple markets and gains from buyouts to prove beneficial. However, the pandemic-led challenges and lower selling days remain concerning for Q4.

Zacks Investment Research - 2 months ago

Colfax's (CFX) Q3 earnings reflect the impacts of poor product demand due to the pandemic, forex woes and a fall in margin. For Q4, it predicts a sequential rise in sales and earnings.

Seeking Alpha - 2 months ago

Colfax Corporation (CFX) CEO Matt Trerotola on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Colfax (CFX) delivered earnings and revenue surprises of 2.50% and 6.13%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 2 months ago

ANNAPOLIS JUNCTION, MD, Oct. 29, 2020 (GLOBE NEWSWIRE) --  Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the third quarter...

Zacks Investment Research - 2 months ago

Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 3 months ago

Annapolis Junction, MD, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing...

Zacks Investment Research - 3 months ago

Colfax (CFX) to benefit from growth opportunities in the Fabrication Technology and Medical Technology segments. Also, business in multiple end markets and cost-reduction actions are other tai...

Zacks Investment Research - 4 months ago

Colfax's (CFX) focus on innovation and product launches along with cost-saving measures might aid performances in the quarters ahead. Adversities caused by the pandemic and high debts are conc...

Forbes - 4 months ago

It appears that investors are starting to take their chips off the table after an incredible run off the coronavirus-led market lows in March. For investors who anticipate that this wave of se...

Other stocks mentioned: GT, NAV, PLUG, VTR
Zacks Investment Research - 4 months ago

Colfax (CFX) reported earnings 30 days ago. What's next for the stock?

Seeking Alpha - 4 months ago

Colfax's Rate Of Recovery Will Demonstrate The Strength Of Newly Transformed Portfolio

Seeking Alpha - 5 months ago

Colfax's (CFX) CEO Matt Trerotola on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Colfax's (CFX) Q2 results reflect the adverse impacts of the pandemic on product demand and forex woes. It predicts generating sequentially higher profits and positive cash flow in Q3.

Zacks Investment Research - 5 months ago

Colfax (CFX) delivered earnings and revenue surprises of 50.00% and 2.91%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 5 months ago

•         Achieved objectives to address COVID-19 impacts, including generating positive cash flow

Zacks Investment Research - 5 months ago

Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 5 months ago

Colfax (CFX), with 41% growth in shares in the past three months, benefits from the overall revival in the broader market, buyout impacts, solid product offerings and cost-saving measures.

Zacks Investment Research - 5 months ago

Colfax (CFX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

GlobeNewsWire - 6 months ago

Annapolis Junction, MD, July 14, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release provid...

Zacks Investment Research - 7 months ago

Colfax (CFX) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 7 months ago

Colfax (CFX), with a 23% decline in shares so far in 2020, faces the adverse impacts of the pandemic. High debts and forex woes are other concerns.

Seeking Alpha - 8 months ago

Colfax Corporation (CFX) CEO Matthew Trerotola on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Colfax's (CFX) Q1 results reflect the adverse impacts of the pandemic and contributions from the DJO Global buyout. It withdraws projections for 2020, while expects demand to be the lowest in ...

Zacks Investment Research - 8 months ago

Colfax (CFX) delivered earnings and revenue surprises of 2.70% and 3.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 8 months ago

Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 8 months ago

Colfax (CFX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

GlobeNewsWire - 8 months ago

ANNAPOLIS JUNCTION, MD , April 27, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that due to public health considerations...

Zacks Investment Research - 9 months ago

Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses, productivity actions and acquisitions. However, rising cost of sales and high debt remain concerns.

Zacks Investment Research - 9 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 9 months ago

Colfax (CFX) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 10 months ago

Is Colfax (CFX) a great pick from the value investor's perspective right now? Read on to know more.

Zacks Investment Research - 10 months ago

Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses and productivity actions, and gains from acquired assets. Cost of sales witnesses a rise.

Seeking Alpha - 10 months ago

Colfax Corporation (CFX) CEO Matt Trerotola on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Colfax's (CFX) fourth-quarter 2019 results benefit from growth in existing businesses and acquired assets despite forex woes.

Zacks Investment Research - 10 months ago

Colfax (CFX) delivered earnings and revenue surprises of 8.93% and 0.70%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 11 months ago

Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Colfax (CFX) is likely to gain from acquired assets, healthy medical technology business and emerging market exposure. High costs, forex woes and huge debts are concerns.

Zacks Investment Research - 1 year ago

Colfax (CFX) benefits from acquisitions, productivity actions and product developments. However, escalating costs and a highly leveraged balance sheet are headwinds.

GlobeNewsWire - 1 year ago

Annapolis Junction, MD, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading global manufacturer of medical technology and fabrication technology products and services...

Zacks Investment Research - 1 year ago

Colfax (CFX) is likely to continue benefiting from acquisitions, productivity actions and product developments. However, a highly leveraged balance sheet remains a concern.

Zacks Investment Research - 1 year ago

Colfax's (CFX) third-quarter 2019 results benefit from improved sales performance, with buyouts playing a significant role.

Seeking Alpha - 1 year ago

Colfax Corporation (CFX) CEO Matt Trerotola on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Colfax (CFX) delivered earnings and revenue surprises of 8.70% and -0.10%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 1 year ago

Annapolis Junction, MD, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax”) (NYSE: CFX), today announced that it will be presenting at Baird’s 2019 Global Industrial Conference i...

Zacks Investment Research - 1 year ago

Colfax (CFX) is likely to gain from opportunities in fabrication technology and orthopedic solutions businesses, buyouts, and emerging market exposure. High costs, huge debts and forex woes ar...

About CFX

Colfax Corporation operates as a diversified technology company worldwide. The company operates through two segments, Medical Technology and Fabrication Technology. The Medical Technology segment offers orthopedic solutions, including orthopedic devices and braces, reconstructive and surgical implants, footwear, bone growth stimulators, and software and services spanning the full continuum of patient care, as well as injury prevention, rehabilitation, pain management, and physical therapy under the Aircast, Chattanooga, CMF, Compex, DonJoy, Pro... [Read more...]

Industry
Specialty Industrial Machinery
IPO Date
May 8, 2008
CEO
Matthew Trerotola
Employees
15,000
Stock Exchange
NYSE
Ticker Symbol
CFX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 18 analysts, the average rating for CFX stock is "Buy." The 12-month stock price forecast is 43.00, which is an increase of 11.03% from the latest price.

Price Target
$43.00
(11.03% upside)
Analyst Consensus: Buy